Home Cart 0 Sign in  
X

[ CAS No. 13721-01-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 13721-01-2
Chemical Structure| 13721-01-2
Chemical Structure| 13721-01-2
Structure of 13721-01-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 13721-01-2 ]

Related Doc. of [ 13721-01-2 ]

Alternatived Products of [ 13721-01-2 ]

Product Details of [ 13721-01-2 ]

CAS No. :13721-01-2 MDL No. :MFCD00498984
Formula : C10H7NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :ILNJBIQQAIIMEY-UHFFFAOYSA-N
M.W : 189.17 Pubchem ID :220875
Synonyms :

Calculated chemistry of [ 13721-01-2 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 51.53
TPSA : 70.16 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.15 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.75
Log Po/w (XLOGP3) : 1.84
Log Po/w (WLOGP) : 1.23
Log Po/w (MLOGP) : 0.41
Log Po/w (SILICOS-IT) : 1.94
Consensus Log Po/w : 1.23

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.63
Solubility : 0.439 mg/ml ; 0.00232 mol/l
Class : Soluble
Log S (Ali) : -2.93
Solubility : 0.22 mg/ml ; 0.00116 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.98
Solubility : 0.197 mg/ml ; 0.00104 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.39

Safety of [ 13721-01-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 13721-01-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 13721-01-2 ]
  • Downstream synthetic route of [ 13721-01-2 ]

[ 13721-01-2 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 26892-90-0 ]
  • [ 34785-11-0 ]
  • [ 13721-01-2 ]
Reference: [1] Patent: US2011/98311, 2011, A1,
  • 2
  • [ 26892-90-0 ]
  • [ 13721-01-2 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: for 2 h; Heating / reflux
Stage #2: With hydrogenchloride In water
4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
4-Hydroxyquinoline-3-carboxylic acid ethyl ester (15 g, 69 mmol) was suspended in sodium hydroxide solution (2N, 150 mL) and stirred for 2 h at reflux.
After cooling, the mixture was filtered, and the filtrate was acidified to pH 4 with 2N HCl.
The resulting precipitate was collected via filtration, washed with water and dried under vacuum to give 4-oxo-1,4-dihydroquinoline-3-carboxylic acid as a pale white solid (10.5 g, 92percent).
1H NMR (DMSO-d6) δ 15.34 (s, 1H), 13.42 (s, 1H), 8.89 (s, 1H), 8.28 (d, J=8.0 Hz, 1H), 7.88 (m, 1H), 7.81 (d, J=8.4 Hz, 1H), 7.60 (m, 1H).
92%
Stage #1: for 2 h; Heating / reflux
Stage #2: With hydrogenchloride In water
[0219] 4-Hydroxyquinoline-3-carboxylic acid ethyl ester (15 g, 69 mmol) was suspended in sodium hydroxide solution (2N, 150 mL) and stirred for 2 h at reflux. After cooling, the mixture was filtered, and the filtrate was acidified to pH 4 with 2N HCl. The <n="49"/>resulting precipitate was collected via filtration, washed with water and dried under vacuum to give 4-oxo-l,4-dihydroquinoline-3-carboxylic acid as a pale white solid (10.5 g, 92 percent). 1H NMR (DMSO-flfe) δ 15.34 (s, 1 H), 13.42 (s, 1 H), 8.89 (s, IH), 8.28 (d, J= 8.0 Hz, IH), 7.88 (m, IH), 7.81 (d, J = 8.4 Hz, IH), 7.60 (m, IH).
10.5 g for 2 h; Reflux 4-Hydroxyquinoline-3-carboxylic acid ethyl ester (15 g, 69 mmol) was suspended in sodium hydroxide solution (2N, 150 mL) and stirred for 2 h at reflux. After cooling, the mixture was filtered, and the filtrate was acidified to pH 4 with 2N HCl. The resulting precipitate was collected via filtration, washed with water and dried under vacuum to give 4-oxo-l,4-dihydroquinoline-3-carboxylic acid as a pale white solid (10.5 g, 92 percent). 1H NMR (DMSO-
10.5 g for 2 h; Reflux 4-Hydroxyquinoline-3-carboxylic acid ethyl ester (15 g, 69 mmol) was suspended in sodium hydroxide solution (2N, 150 mL) and stirred for 2 h at reflux. After cooling, the mixture was filtered, and the filtrate was acidified to pH 4 with 2N HCl. The resulting precipitate was collected via filtration, washed with water and dried under vacuum to give 4-oxo-1,4-dihydroquinoline-3-carboxylic acid as a pale white solid (10.5 g, 92 percent).1H NMR (DMSO-d6) δ 15.34 (s, 1 H), 13.42 (s, 1 H), 8.89 (s, 1H), 8.28 (d, J = 8.0 Hz, 1H), 7.88 (m, 1H), 7.81 (d, J = 8.4 Hz, 1H), 7.60 (m, 1H).
10.5 g for 2 h; Reflux Step C:
4-Oxo-1,4-dihydroquinoline-3-carboxylic acid
4-Hydroxyquinoline-3-carboxylic acid ethyl ester (15 g, 69 mmol) was suspended in a sodium hydroxide solution (2N, 150 mL) and stirred for 2 h at reflux.
After cooling, the mixture was filtered, and the filtrate was acidified to pH 4 with 2N HCl.
The resulting precipitate was collected via filtration, washed with water and dried under vacuum to give 4-oxo-1,4-dihydroquinoline-3-carboxylic acid as a pale white solid (10.5 g, 92percent).
1H NMR (DMSO-d6) δ 15.34 (s, 1H), 13.42 (s, 1H), 8.89 (s, 1H), 8.28 (d, J=8.0 Hz, 1H), 7.88 (m, 1H), 7.81 (d, J=8.4 Hz, 1H), 7.60 (m, 1H) ppm.
10.5 g for 2 h; Reflux 4-Hydroxyquinoline-3-carboxylic acid ethyl ester (15 g, 69 mmol) was suspended in sodium hydroxide solution (2N, 150 mL) and stirred for 2 h at reflux. After cooling, the mixture was filtered, and the filtrate was acidified to pH 4 with 2N HC1. The resulting precipitate was collected via filtration, washed with water and dried under vacuum to give 4-oxo-l,4-dihydroquinoline-3-carboxylic acid as a pale white solid (10.5 g, 92 percent). lU NMR (DMSO-4) δ 15.34 (s, 1 H), 13.42 (s, 1 H), 8.89 (s, 1H), 8.28 (d, J = 8.0 Hz, 1H), 7.88 (m, 1H), 7.81 (d, J = 8.4 Hz, 1H), 7.60 (m, 1H).

Reference: [1] Patent: US2008/90864, 2008, A1, . Location in patent: Page/Page column 7
[2] Patent: WO2007/79139, 2007, A2, . Location in patent: Page/Page column 46; 47
[3] Patent: US2012/309758, 2012, A1, . Location in patent: Page/Page column 61
[4] Patent: US2015/231142, 2015, A1, . Location in patent: Paragraph 0352
[5] Patent: WO2018/64632, 2018, A1, . Location in patent: Paragraph 00215; 00216
[6] Patent: WO2018/107100, 2018, A1, . Location in patent: Paragraph 00234; 00235
[7] Patent: US2018/280349, 2018, A1, . Location in patent: Paragraph 0097
[8] Patent: WO2018/227049, 2018, A1, . Location in patent: Paragraph 00206; 00207
  • 3
  • [ 52980-28-6 ]
  • [ 13721-01-2 ]
YieldReaction ConditionsOperation in experiment
80% at 0 - 80℃; for 16 h; Ex mple 2: Synthesis of 4-Oxo-l,4-dihydroquinoline-3-carboxylic acid (3): (0084) (0085) To a suspension of ethyl 4-oxo- l,4-dihydroquinoline-3-carboxylate (2) (0.5 g, 2.30 mmol) in THF (10 mL), a solution of aqueous 1 M LiOH (aq) (4.60 mL, 4.60 mmol) was added drop wise at 0 °C, and then the reaction mixture was heated at 80 °C for 16h. Reaction mass was evaporated to dryness, dissolved in H20 (5 mL), washed with diethyl ether (2x5 mL).The aqueous layer was acidified with 1 M HC1 (aq),compound thus precipitated was filtered, dried under vacuum to give desired compound as off-white solid. Yield: (0.35g; 80percent) 1H NMR (400MHz ,DMSO-d6) δ = 15.36 (brs, 1H), 13.43 (brs, 1H), 8.91 (s, 1H), 8.31 (d, J = 8.3 Hz, 1H), 7.98 - 7.75 (m, 2H), 7.62 (t, J = 7.6 Hz, 1H).
75% With sodium hydroxide In ethanol for 5 h; Reflux General procedure: A suspension of ester 3e–k (2 mmol) in 4percent NaOHhydroalcoholic solution (5 ml) was refluxed until no startingmaterial could be detected by Thin Layer Chromatography(5 h). After cooling, the mixture was completely acidifiedby adding concentrated HCl and the solid obtained wascollected by filtration, washed with water, and crystallizedfrom ethanol to afford compound 4e–k. 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid (4e) Starting from 3e (1 g); Yield (white powder): 600 mg(75 percent); m.p. 280 °C (decomposed); IR (KBr) νmax1400–1600 (aromatic), 1717 (carbonyl), 2790–3260 (acidicOH) cm−1; 1H-NMR (DMSO-d6, 500 MHz) δ = 7.59–7.63 (1H, t, J = 7.2 Hz, H6), 7.83 (1H, d, J = 8.2 Hz, H8), 7.90(1H, t, J = 7.0 Hz, H7), 8.30 (1H, d, J = 7.3 Hz, H5), 8.90(1H, s, H2), 13.42 (1H, br s, enolic OH), 15.34 (1H, br s,carboxylic OH); 13C-NMR (DMSO-d6, 60 MHz) δ = 105.3(C, C-3), 119.7 (CH, C-9), 123.6 (CH, C-7), 125.6 (CH,C-6), 125.9 (C, C-5), 133.9 (CH, C-8), 138.5 (C,C-10), 158.9 (CH, C-2), 167.2 (C,COOH), 178.5 (C, C=O);LC-MS (ESI) m/z 212.1 (M+Na+); Anal. Calcd. forC10H7NO3: C, 63.49; H, 3.73; N, 7.40. Found: 63.62; H,3.96; N, 7.69.
7.5 g at 80 - 85℃; for 3 h; In a clean round bottom flask, ethyl 4-oxo-l, 4-dihydroquinoline-3-carboxylate (10.0 gm) was charged to a solution of sodium hydroxide (3.7 gm) in 13.0 ml water. The reaction mass was heated for 3.0 hr at 80-85 C and then cooled to 25-30. To this was added 0.10 gm of activated charcoal and filtered. The pH was adjusted using con HCL and the product was filtered and washed with water. The wet cake slurried in methanol at 25 -30 C and filtered. The product was dried under vacuum at 50.0 C to get 7.50 gm of title productPurity by HPLC - 99.75 percent
Reference: [1] Chemical Communications, 2005, # 43, p. 5438 - 5440
[2] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 6, p. 3169 - 3173
[3] Patent: WO2017/208253, 2017, A2, . Location in patent: Page/Page column 13-14
[4] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5405 - 5418
[5] Medicinal Chemistry Research, 2016, vol. 25, # 9, p. 1861 - 1876
[6] Journal of Medicinal Chemistry, 2006, vol. 49, # 22, p. 6443 - 6450
[7] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 17, p. 5261 - 5265
[8] Patent: WO2010/108155, 2010, A1, . Location in patent: Page/Page column 14; 33-34
[9] Patent: WO2010/108162, 2010, A1, . Location in patent: Page/Page column 62-64
[10] Patent: US2011/230519, 2011, A1, . Location in patent: Page/Page column 15-16
[11] Patent: WO2013/67410, 2013, A1, . Location in patent: Paragraph 0083
[12] Patent: WO2013/185112, 2013, A1, . Location in patent: Paragraph 00536
[13] Patent: WO2014/71122, 2014, A1, . Location in patent: Paragraph 00156; 00321; 00322; 00325; 00327
[14] Patent: WO2014/118805, 2014, A1, . Location in patent: Paragraph 0290
[15] Patent: US2014/221424, 2014, A1, . Location in patent: Paragraph 0077
[16] Patent: WO2015/73231, 2015, A1, . Location in patent: Paragraph 00340-00341
[17] Patent: WO2015/189560, 2015, A1,
[18] Patent: US2017/96397, 2017, A1, . Location in patent: Paragraph 0093
  • 4
  • [ 26892-90-0 ]
  • [ 34785-11-0 ]
  • [ 13721-01-2 ]
Reference: [1] Patent: US2011/98311, 2011, A1,
  • 5
  • [ 54535-22-7 ]
  • [ 13721-01-2 ]
Reference: [1] Chemical Communications, 2005, # 43, p. 5438 - 5440
[2] Journal of Medicinal Chemistry, 2006, vol. 49, # 22, p. 6443 - 6450
[3] Patent: US2011/230519, 2011, A1,
[4] Patent: US2012/309758, 2012, A1,
[5] Patent: WO2013/67410, 2013, A1,
[6] Patent: WO2014/71122, 2014, A1,
[7] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5405 - 5418
[8] Patent: WO2014/118805, 2014, A1,
[9] Patent: WO2015/73231, 2015, A1,
[10] Patent: US2015/231142, 2015, A1,
[11] Patent: WO2015/189560, 2015, A1,
[12] Medicinal Chemistry Research, 2016, vol. 25, # 9, p. 1861 - 1876
[13] Patent: WO2007/79139, 2007, A2,
[14] Patent: US2011/98311, 2011, A1,
[15] Patent: WO2018/64632, 2018, A1,
[16] Patent: WO2018/107100, 2018, A1,
[17] Patent: US2018/280349, 2018, A1,
[18] Patent: US2017/96397, 2017, A1,
[19] Patent: WO2018/227049, 2018, A1,
  • 6
  • [ 62-53-3 ]
  • [ 13721-01-2 ]
Reference: [1] Patent: US2011/230519, 2011, A1,
[2] Patent: US2012/309758, 2012, A1,
[3] Patent: WO2013/67410, 2013, A1,
[4] Patent: WO2013/185112, 2013, A1,
[5] Patent: WO2014/71122, 2014, A1,
[6] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5405 - 5418
[7] Patent: WO2014/118805, 2014, A1,
[8] Patent: WO2015/73231, 2015, A1,
[9] Patent: US2015/231142, 2015, A1,
[10] Patent: WO2015/189560, 2015, A1,
[11] Medicinal Chemistry Research, 2016, vol. 25, # 9, p. 1861 - 1876
[12] Patent: WO2007/79139, 2007, A2,
[13] Patent: WO2018/64632, 2018, A1,
[14] Patent: WO2018/107100, 2018, A1,
[15] Patent: US2018/280349, 2018, A1,
[16] Patent: US2017/96397, 2017, A1,
[17] Patent: WO2018/227049, 2018, A1,
  • 7
  • [ 61707-79-7 ]
  • [ 13721-01-2 ]
Reference: [1] Heterocycles, 1999, vol. 51, # 10, p. 2377 - 2384
  • 8
  • [ 4916-29-4 ]
  • [ 13721-01-2 ]
Reference: [1] Heterocycles, 1999, vol. 51, # 10, p. 2377 - 2384
  • 9
  • [ 61707-75-3 ]
  • [ 13721-01-2 ]
Reference: [1] Heterocycles, 1999, vol. 51, # 10, p. 2377 - 2384
  • 10
  • [ 61707-70-8 ]
  • [ 13721-01-2 ]
Reference: [1] Heterocycles, 1999, vol. 51, # 10, p. 2377 - 2384
  • 11
  • [ 251986-52-4 ]
  • [ 13721-01-2 ]
Reference: [1] Heterocycles, 1999, vol. 51, # 10, p. 2377 - 2384
  • 12
  • [ 108-88-3 ]
  • [ 13721-01-2 ]
Reference: [1] Patent: US2014/221424, 2014, A1,
  • 13
  • [ 552-16-9 ]
  • [ 13721-01-2 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 6, p. 3169 - 3173
  • 14
  • [ 52119-39-8 ]
  • [ 13721-01-2 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2017, vol. 54, # 6, p. 3169 - 3173
  • 15
  • [ 778-82-5 ]
  • [ 13721-01-2 ]
Reference: [1] Patent: WO2017/208253, 2017, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 13721-01-2 ]

Ketones

Chemical Structure| 52980-28-6

[ 52980-28-6 ]

Ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate

Similarity: 0.91

Chemical Structure| 948573-55-5

[ 948573-55-5 ]

4-Oxo-1,4-dihydroquinoline-7-carboxylic acid

Similarity: 0.87

Chemical Structure| 77156-75-3

[ 77156-75-3 ]

Ethyl 8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate

Similarity: 0.86

Chemical Structure| 863785-96-0

[ 863785-96-0 ]

Methyl 4-oxo-1,4-dihydroquinoline-7-carboxylate

Similarity: 0.84

Chemical Structure| 58781-08-1

[ 58781-08-1 ]

4-Oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylic acid

Similarity: 0.80

Carboxylic Acids

Chemical Structure| 948573-55-5

[ 948573-55-5 ]

4-Oxo-1,4-dihydroquinoline-7-carboxylic acid

Similarity: 0.87

Chemical Structure| 858515-65-8

[ 858515-65-8 ]

4-Methyl-1H-indole-3-carboxylic acid

Similarity: 0.86

Chemical Structure| 771-50-6

[ 771-50-6 ]

1H-Indole-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 10242-02-1

[ 10242-02-1 ]

5-Methyl-1H-indole-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 1159511-18-8

[ 1159511-18-8 ]

3-Methyl-1H-indole-4-carboxylic acid

Similarity: 0.83

Related Parent Nucleus of
[ 13721-01-2 ]

Quinolines

Chemical Structure| 52980-28-6

[ 52980-28-6 ]

Ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate

Similarity: 0.91

Chemical Structure| 948573-55-5

[ 948573-55-5 ]

4-Oxo-1,4-dihydroquinoline-7-carboxylic acid

Similarity: 0.87

Chemical Structure| 77156-75-3

[ 77156-75-3 ]

Ethyl 8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate

Similarity: 0.86

Chemical Structure| 863785-96-0

[ 863785-96-0 ]

Methyl 4-oxo-1,4-dihydroquinoline-7-carboxylate

Similarity: 0.84

Chemical Structure| 338747-41-4

[ 338747-41-4 ]

1-(4-Methoxybenzyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Similarity: 0.78